Literature DB >> 28731509

Keeping safe. Continuous glucose monitoring (CGM) in persons with Type 1 diabetes and impaired awareness of hypoglycaemia: a qualitative study.

A F Vloemans1, C A J van Beers2, M de Wit1, W Cleijne1, S M Rondags1, P H Geelhoed-Duijvestijn3, M H H Kramer2, E H Serné2, F J Snoek1,4.   

Abstract

AIM: To further our understanding of individual use and experience of continuous glucose monitoring (CGM) in adults with Type 1 diabetes and impaired awareness of hypoglycaemia, we conducted a qualitative study supplementary to a randomized controlled trial, using semi-structured interviews.
METHODS: Twenty-three participants of the IN CONTROL trial were interviewed within 4 weeks after the last study visit. The interview centred around experiences of CGM, taking into account the person's expectations prior to the trial. The interview was semi-structured, using open-ended questions and, if needed, prompts were offered to elicit further responses. Using thematic analysis, the interview transcripts were coded independently by three members of the research team. The consolidated criteria for reporting qualitative research (COREQ) were followed.
RESULTS: Overall, CGM was experienced as helpful in gaining more insight into glucose variability, and temporarily improved sense of control, reduced distress and made participants less dependent on others. However, some participants experienced confrontation with CGM output as intrusive, while some reported frustration due to failing technique and difficulty trusting the device. Participants reported active and passive self-management behaviours mirroring individual differences in attitudes and coping styles.
CONCLUSIONS: In adults with Type 1 diabetes at risk of recurrent hypoglycaemia due to impaired awareness of hypoglycaemia, CGM use enhances a sense of control and safety for most, but not all. Future studies should further explore differential use of CGM in this population in the context of active and passive self-management styles.
© 2017 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28731509     DOI: 10.1111/dme.13429

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  5 in total

1.  Comparison of venous, capillary and interstitial blood glucose data measured during hyperbaric oxygen treatment from patients with diabetes mellitus.

Authors:  Carol Baines; Don Vicendese; David Cooper; William McGuiness; Charne Miller
Journal:  Diving Hyperb Med       Date:  2021-09-30       Impact factor: 1.228

Review 2.  Biopsychosocial Factors Associated With Satisfaction and Sustained Use of Artificial Pancreas Technology and Its Components: a Call to the Technology Field.

Authors:  Gregory P Forlenza; Laurel H Messer; Cari Berget; R Paul Wadwa; Kimberly A Driscoll
Journal:  Curr Diab Rep       Date:  2018-09-26       Impact factor: 4.810

3.  Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study.

Authors:  Monika Reddy; Narvada Jugnee; Sinthuka Anantharaja; Nick Oliver
Journal:  Diabetes Technol Ther       Date:  2018-09-28       Impact factor: 6.118

4.  Therapy adjustments in people with type 1 diabetes with impaired hypoglycemia awareness on multiple daily injections using real-time continuous glucose monitoring: a mechanistic analysis of the HypoDE study.

Authors:  Delia Waldenmaier; Guido Freckmann; Stefan Pleus; Norbert Hermanns; Dominic Ehrmann; Lutz Heinemann; Cornelia Haug
Journal:  BMJ Open Diabetes Res Care       Date:  2021-04

5.  Associations of Time in Range and Other Continuous Glucose Monitoring-Derived Metrics With Well-Being and Patient-Reported Outcomes: Overview and Trends.

Authors:  Dominic Ehrmann; Lilli Priesterroth; Andreas Schmitt; Bernhard Kulzer; Norbert Hermanns
Journal:  Diabetes Spectr       Date:  2021-05-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.